It is described that the released CXCL12 and IGF1 produced by MSCs activate the PI3K/AKT signaling pathway in breast cancer cells and then shift the cancer cell population towards more bone metastatic ones (166). This evidence concerns the gene CXCL12 and breast carcinoma.